Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 526 AL 540

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges

Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA.

Cell Mol Life Sci. 2022 Apr 2;79(4):219. doi: 10.1007/s00018-022-04225-1.

Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases

Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B.

Drug Discov Today. 2022 Jul;27(7):1994-2007. doi: 10.1016/j.drudis.2022.04.003. Epub 2022 Apr 6.

Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review

Klose J, Griehl C, Roßner S, Schilling S.

Biomolecules. 2022 May 12;12(5):694. doi: 10.3390/biom12050694.

Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review

Martins B, Vieira M, Delerue-Matos C, Grosso C, Soares C.

Mar Drugs. 2022 May 28;20(6):362. doi: 10.3390/md20060362.

Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases

Azman KF, Zakaria R.

Int J Mol Sci. 2022 Jun 19;23(12):6827. doi: 10.3390/ijms23126827.

Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases

Zhang Y, Wang Y, Zhao Z, Peng W, Wang P, Xu X, Zhao C.

Eur J Pharmacol. 2022 Sep 15;931:175178. doi: 10.1016/j.ejphar.2022.175178. Epub 2022 Aug 7.

Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders

De Plano LM, Calabrese G, Conoci S, Guglielmino SPP, Oddo S, Caccamo A.

Int J Mol Sci. 2022 Aug 5;23(15):8714. doi: 10.3390/ijms23158714.

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

Behl T, Makkar R, Sehgal A, Sharma N, Singh S, Albratty M, Najmi A, Meraya AM, Bungau SG.

Molecules. 2022 Aug 4;27(15):4970. doi: 10.3390/molecules27154970.

Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.

Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.

The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease

Calderaro A, Patanè GT, Tellone E, Barreca D, Ficarra S, Misiti F, Laganà G.

Int J Mol Sci. 2022 Nov 27;23(23):14835. doi: 10.3390/ijms232314835.

Acylhydrazones and Their Biological Activity: A Review

Socea LI, Barbuceanu SF, Pahontu EM, Dumitru AC, Nitulescu GM, Sfetea RC, Apostol TV.

Molecules. 2022 Dec 9;27(24):8719. doi: 10.3390/molecules27248719.

A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group

Kanguru L, Logan G, Waddel B, Smith C, Molesworth A, Knight R.

BMC Geriatr. 2022 Jul 20;22(1):603. doi: 10.1186/s12877-022-03280-4.

Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders

Hölscher C.

Br J Pharmacol. 2022 Feb;179(4):695-714. doi: 10.1111/bph.15508. Epub 2021 May 29.

Advancements and future directions in research of the roles of insulin in amyloid diseases

Miller Y.

Biophys Chem. 2022 Feb;281:106720. doi: 10.1016/j.bpc.2021.106720. Epub 2021 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias